The role of mitochondria in ischemia/reperfusion injury
Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance1
The effect of acute rejection and cyclosporin A—treatment on induction of platelet-derived growth factor and its receptors during the development of chronic rat renal allograft rejection1
Treatment of streptozotocin-induced diabetes mellitus by transplantation of islet cells plus bone marrow cells via portal vein in rats1
Survival of fetal skin grafts is prolonged on the human peripheral blood lymphocyte reconstituted–severe combined immunodeficient mouse/skin allograft model1
TCV-116, an angiotensin II type 1 receptor antagonist, reduces hepatic ischemia-reperfusion injury in rats
Modulation of catecholamine responsiveness and β-adrenergic receptor/adenylyl cyclase pathway during cardiac allograft rejection1 2
Epstein-Barr virus-negative precursor B cell lymphoblastic lymphoma after liver transplantation: a unique form of posttransplant lymphoproliferative disease
Bronchiolitis obliterans organizing pneumonia in an orthotopic liver transplant patient1
The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol1
Pancreas allograft biopsy: safety of percutaneous biopsy—results of a large experience
Temporal relationships between acute cellular rejection features and increased mucosal fibrosis in the early posttransplant period of human small intestinal allografts
Zoom endoscopic evaluation of rejection in living-related small bowel transplantation
Chronic parvovirus B19 infection in a pediatric lung transplanted patient
Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluation
High transforming growth factor-β and extracellular matrix mRNA response in renal allografts during early acute rejection is associated with absence of chronic rejection1
Transplant tumor registry: donors with central nervous system tumors1
The outcome of liver grafts procured from hepatitis C-positive donors
Diabetogenic effect of tacrolimus in South African patients undergoing kidney transplantation1
Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients
Clinical impact of human herpesvirus 6 infection after liver transplantation
Combined liver and kidney transplantation in a patient with sickle cell disease
Disseminated varicella infection in adult renal allograft recipients: four cases and a review of the literature
Effect of kidney transplantation on bone mass and body composition in males
Cost-effectiveness of cadaveric and living-donor liver transplantation
Hypertension is an independent predictor of delayed graft function and worse renal function only in kidneys with chronic pathological lesions
Temporary auxiliary liver transplantation from a living donor to an adult recipient with familial amyloid polyneuropathy1
Diameter of the infrarenal aorta and the iliac arteries in children
Inhibition of CD40-mediated endothelial cell activation with antisense oligonucleotides
Is there MHC Class II restriction of the response to MHC Class I in transplant patients?
Heart allograft tolerance without development of posttransplant cardiac allograft vasculopathy in chimerism-based, drug-induced tolerance1
Expression of growth arrest–specific gene 6 and its receptors in a rat model of chronic renal transplant rejection
Topical use of cidofovir induced acute renal failure
Treatment of hyperhomocysteinemia with folic acid reduces oxidative stress in renal transplant recipients
Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease1
Long-term outcome of lung transplant is predicted by the number of HLA-DR Mismatches
Long-term outcome of lung transplant is predicted by the number of HLA-DR Mismatches
Intestinal lymphoma perforations as a consequence of highly effective anti-CD20 antibody therapy